Eversept Partners’s Neuronetics STIM Stock Holding History
Bought
Maintained
Sold
Other funds holding STIM
Eversept Partners's STIM Position: Q3 2026 in Review
Eversept Partners opened a new position in Neuronetics (STIM) in Q3 2026: 1,402,548 shares worth $3.28M. The stake represents 0.18% of the portfolio and ranks #67 among its holdings.
71 funds tracked by Wall St. Rank hold STIM as of Q3 2026.
- Eversept Partners held 1,402,548 shares of Neuronetics worth $3.28M as of Q3 2026.
- Neuronetics was a new Eversept Partners position in Q3 2026.
- Neuronetics made up 0.18% of Eversept Partners's portfolio in Q3 2026, its #67 holding.
- 71 funds tracked by Wall St. Rank held Neuronetics as of Q3 2026.
Based on Eversept Partners's 13F filing for Q3 2026, filed 16 Nov 2026.